May 12, 2020 The Honourable Navdeep Bains, P.C., M.P. Minister of Innovation, Science and Industry C.D. Howe Building 235 Queen Street Ottawa, Ontario K1A 0H5 Dear Minister Bains; On behalf… Read More
Qu’s Site-Specific Immunomodulator (SSI) technology is recognized to be uniquely suited to address the problem the world is collectively grappling with – a novel emerging viral infection where there is… Read More
Vancouver, BC – May 14, 2020 – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and… Read More
SAN DIEGO, May 13, 2020 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, announced its financial… Read More
Introduction CIIP is pleased to announce its collaboration with NRC-IRAP on the EUREKA call for proposal. This call for proposals for joint research and development (R&D) projects addressing short to… Read More
